Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans

Article

Jaimy Lee May 28, 2026 3 Min Read

That means millions more Americans may get access to Lilly’s new GLP-1 pill Foundayo or the GLP-1 injection Zepbound.

Join thousands of traders and investors. Discover how specific trading strategies work — and get started with your investment journey.

Create Account